We have just completed a new case report that presents one of the most striking findings yet in the debate over COVID-19 “vaccine” turbo cancers: vaccine spike-encoding plasmid DNA was recovered directly from an extremely rare, hyper-aggressive heart tumor.
The McCullough Foundation paper is titled, “Fatal Cardiac Intimal Sarcoma in a 35-Year-Old Male Following COVID-19 mRNA Vaccination: Plasmid DNA Fragments Encoding the S-Protein Detected in Tumor Tissue.”
The patient was a 35-year-old man with no personal or family history of cancer and no identified hereditary cancer predisposition. He received Pfizer-BioNTech BNT162b2 on April 10 and May 4, 2021. Just 170 days after the first dose, doctors discovered a large tumor filling the left atrium of his heart along with multiple brain metastases.
Three days later, surgeons removed a 9.0 × 7.0 × 5.3 cm mass from his heart. Pathology confirmed a high-grade cardiac intimal sarcoma, an exceptionally rare and aggressive cancer. Molecular testing found the characteristic abnormalities MDM2 and KDR amplification, while whole-body PET/CT found no other primary tumor elsewhere in the body.
The cancer progressed at an extraordinary pace. Despite open-heart surgery, chemotherapy, radiation, gamma knife treatment, and four brain surgeries, new metastases continued to appear. He ultimately suffered bleeding into a brainstem tumor and died 675 days after diagnosis.
What makes this case especially important is that the growth rate could actually be measured. One brain metastasis grew from about 4 millimeters to 35 millimeters in only 94 days. That works out to a tumor volume doubling time of roughly 10 days.
Then came the most remarkable finding. Archived tissue from the original heart tumor was tested for vaccine components.
Hellbound and Down 